Un enfoque parcial de la igualdad de género debilita a los ODS: es hora de una acción transversal.

Morgan R, Dhatt R, Kharel C, Muraya K.

Glob Health Promot. 2020. ; 27 : 205-208. doi: 10.1177/1757975920949745.

Une approche disparate de l’égalité de genre affaiblit les ODD : le temps d’une action transversale.

Morgan R, Dhatt R, Kharel C, Muraya K.

Glob Health Promot. 2020. ; 27 : 180-183. doi: 10.1177/1757975920949747.

Erratum to: Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study.

Dramowski A, Ong’ayo G, Rehman AM, Whitelaw A, Labi AK, Obeng-Nkrumah N, Ndir A, Magwenzi MT, Onyedibe K, Wolkewitz M, de Kraker MEA, Scott JAG, Aiken AM.

JAC Antimicrob Resist. 2021. ; 3 : dlab037. doi: 10.1093/jacamr/dlab037.

Incentive preferences for community health volunteers in Kenya: findings from a discrete choice experiment.

Abuya T, Mwanga D, Obadha M, Ndwiga C, Odwe G, Kavoo D, Wanyugu J, Warren C, Agarwal S.

BMJ Open. 2021. ; 11 : e048059. doi: 10.1136/bmjopen-2020-048059

Improving statistical power in severe malaria genetic association studies by augmenting phenotypic precision.

Watson JA, Ndila CM, Uyoga S, Macharia A, Nyutu G, Mohammed S, Ngetsa C, Mturi N, Peshu N, Tsofa B, Rockett K, Leopold S, Kingston H, George EC, Maitland K, Day NP, Dondorp AM, Bejon P, Williams T, Holmes CC, White NJ.

Elife. 2021. ; 10 : doi: 10.7554/eLife.69698.

Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya.

Kirubi B, Ong’ang’o J, Nguhiu P, Lönnroth K, Rono A, Sidney-Annerstedt K.

Infect Dis Poverty. 2021. ; 10 : 95. doi: 10.1186/s40249-021-00879-4.

Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study.

Dramowski A, Ong’ayo G, Rehman AM, Whitelaw A, Labi AK, Obeng-Nkrumah N, Ndir A, Magwenzi MT, Onyedibe K, Wolkewitz M, de Kraker MEA, Scott JAG, Aiken AM; MBIRA study collaborators.

JAC Antimicrob Resist. 2021. ; 3 : dlaa130. doi: 10.1093/jacamr/dlaa130.

Chronic Immune Activation and CD4 + T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy.

Wolday D, Ndungu FM, Gómez-Pérez GP, de Wit TFR.

Front Immunol. 2021. ; 12 : doi: 10.3389/fimmu.2021.693269.

What Constitutes Protective Immunity Following Yellow Fever Vaccination?

Mokaya J, Kimathi D, Lambe T, Warimwe GM.

Vaccines (Basel). 2021. ; 9 : 671